申请人:BASILEA PHARMACEUTICA AG
公开号:WO2012171860A1
公开(公告)日:2012-12-20
Compounds of formula (I), wherein A1 represents -0-, -S- or -CH2-; A2 represents -CH2- or -0-; A3 represents C3-C8cycloalkylene; saturated or unsaturated 4 to 8-membered heterocyclodiyl with 1, 2 or 3 heteroatoms selected from nitrogen or oxygen, which group A3 is unsubstituted or substituted; A4 represents C1-C4alkylene, -C(=0)-; G represents aryl or heteroaryl, which is unsubstituted or substituted; X1 represents a nitrogen atom or CR1; R1 represents a hydrogen atom or a halogen atom; R2 represents a hydrogen atom; m is 0 or 1; n is 1; the -(CH2)n- group is unsubstituted or substituted; p is 0 or 1; or pharmaceutically acceptable salts thereof are valuable for use as a medicament for the treatment of bacterial infections.
式(I)的化合物,其中A1代表-O-,-S-或-CH2-;A2代表-CH2-或-O-;A3代表C3-C8环烷基,饱和或不饱和的含有1、2或3个氮或氧杂原子的4到8元杂环二基,其中A3基未取代或取代;A4代表C1-C4烷基,-C(=0)-;G代表芳基或杂芳基,未取代或取代;X1代表氮原子或CR1;R1代表氢原子或卤原子;R2代表氢原子;m为0或1;n为1;-(CH2)n-基未取代或取代;p为0或1;或其在药学上可接受的盐,用作治疗细菌感染的药物。